Blue Review
A newsletter for contracting institutional and professional providers

December 2020

Fighting Fraud, Waste and Abuse: Amniotic Membrane and Amniotic Fluid Products

The Blue Cross and Blue Shield of Illinois (BCBSIL) Special Investigations Department (SID) has become aware of several instances involving experimental, investigational and/or unproven applications of human amniotic membrane products.

SID would like to remind independently contracted providers that the BCBSIL Medical Policy for amniotic membrane and amniotic fluid (SUR704.011) includes specific requirements for the use of human amniotic membrane products such as PalinGen®, AmnioBand® Membrane, Biovance®, EpiCord®, Epifix®, GrafixTM, to be considered medically necessary.

If you are aware of an instance of potential fraud, we encourage you to file a report online or call BCBSIL at 877-272-9741 to make a report. All online reports and calls are confidential, and you may remain anonymous. To view the medical policy for amniotic membrane and amniotic fluid, and access the most up-to-date BCBSIL Medical Policy information, refer to the Medical Policy section of our Provider website.

HMO reminder: Although medical policies can be used as a guide, providers serving HMO members should refer to the HMO Scope of Benefits in the BCBSIL Provider Manual section.